WBA, AmerisourceBergen extend pact
AmerisourceBergen announced earlier this month that it has extended the term of its strategic, long-term relationship with Walgreens Boots Alliance Inc. (WBA) for an additional three years.
CDR
Drug chains step up, do their part to curb Rx abuse
Drug chains are spearheading efforts to fight prescription drug abuse through a range of initiatives. CVS Health reported that its Medication Disposal for Safer Communities program has donated more than 500 drug collection units to law enforcement partners across the U.S.
Enactment of drug abuse bill praised by Rx groups
Enactment of a new law designed to curtail drug abuse while maintaining legitimate access to medications has been hailed by pharmacy groups including the National Association of Chain Drug Stores.
Oral screenings offered at London Drugs
In an effort to raise awareness about oral cancer, London Drugs began offering oral screening clinics at 15 stores in greater Vancouver, British Columbia. The screenings — held between April 25 and May 18 — follow a successful oral cancer screening pilot program that the company began in April 2015.
New NACDS board members, officers assume roles
Alex Gourlay, executive vice president of Walgreens Boots Alliance Inc. and president of Walgreens, was elected vice chairman of the National Association of Chain Drug Stores at its Annual Meeting. Mark Panzer, senior VP of pharmacy, health and wellness at Albertsons, was elected treasurer.
Bayer’s Hayes wins Begley award
Former president of Bayer Consumer Health Tim Hayes received the Robert B. Begley Award at the National Association of Chain Drug Stores Annual Meeting that was held here last month. The award is the highest honor within the chain pharmacy industry.
Top pharmacy staffers recognized by Rite Aid
Rite Aid Corp. recently announced the two winners of the 2015 Vote for Your Favorite Pharmacy Team Member Contest. Sharon Balser, a Rite Aid pharmacy technician from Milford, Mich., and Theresa Forrest, a loyal Rite Aid customer from Gwynn Oak, Md.
Payments issue shows Anderson at his best
National Association of Chain Drug Stores president and CEO Steve Anderson recently provided the group’s members with an update about implementation of the new rule governing reimbursement to pharmacy operators for prescriptions filled under the Medicaid program.
Coughlin helped make Walmart what it is
Amid the dazzling array of industry events that marked April as an exceptional month in the chain drug retailing community, Tom Coughlin, the legendary Walmart executive who led the company through some of its most memorable years, passed away at the age of 67.
CVS Health brand makes NYC premiere
CVS Pharmacy this week held a launch event in Manhattan for its new flagship line of CVS Health brand products.
NACDS readies Vision 2027 for Total Store Expo
The National Association of Chain Drug Stores has announced four companies that will participate in Vision 2027, its futuristic, interactive display at the 2016 NACDS Total Store Expo.
Mylan to acquire Renaissance topicals business
Mylan N.V. has entered an agreement to buy the nonsterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings LLC for $950 million in cash.
Elizabeth Arden to buy P&G’s Christine Aguilera fragrances
Elizabeth Arden Inc. plans to acquire the global license and certain assets for the Christina Aguilera fragrance business from Procter & Gamble International. Financial terms of the agreement weren’t disclosed.
Smith Drug taps Diplomat for specialty Rx services
Smith Drug Co. is providing independent pharmacies access to specialty pharmacy services under a new partnership with Diplomat Pharmacy Inc.
Benzer Pharmacy gains URAC specialty Rx accreditation
Benzer Pharmacy has received specialty pharmacy accreditation from health standards body URAC. The drug chain said that the Benzer Pharmacy in Auburndale, Fla., has been granted full accreditation pursuant to Specialty Pharmacy, Version 2.1.
Aurobindo cleared to market Opana generic
Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for oxymorphone HCl tablets 5 mg and 10 mg, an opioid painkiller. Aurobindo said Thursday that its oxymorphone tablet product is a generic version of Opana tablets (5 mg and 10 mg) from Endo Pharmaceuticals Inc.